Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
This secondary analysis of the Keynote 048 trial examines treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma.
PDF的下载单位、IP信息已删除
(2025-6-4)
Yinxb
嘻嘻哈哈
invisight
失眠的夜蓉
DW
LYSM
OK
xing_xing
wangyumumu
乐空思
极限001
152455
小牛马阿欢
4星
aajhajkahna
小黄
渡人舟
清爽老九
DOC_XIONG
夏沫文献下载
皖公网安备34019202002308
